ESSENTIAL CRO
Trademark domain | |
name | is free? |
---|---|
essential-cro.com | |
essentialcro.com |
The "ESSENTIAL CRO" trademark, serial number 78387269 , was filed on 19th of March 2004 with a mark drawing code of 4000 and its transaction date is 78387269. The attorney assigned is Sandra B. Weiss, attorney docket number 034893-020-0. Since 4th of February 2010, the document can be found in the L40 law office in the publication and issue section. The employee responsible is RIRIE, VERNA BETH and the date it was published for opposition on 10/04/2005. The date when we last checked the status of this trademark was 12/28/2006.
The corresponded responsible for this trademark is Sandra B. Weiss, located at Jones Day, Suite 3500, 77 West Wacker.The state or country where the trademark was organized is IL by Essential Group, Inc.. The legal entity type behing it is a Corporation, located at 1325 Tri State Parkway, Gurnee, IL zip 60015.
GOODS AND/OR SERVICES | |
International Class - 035 - Advertising; business management; business administration; office functions. | |
---|---|
U.S. Class | 102 - Insurance and Financial |
Class Status | 6 - Active |
Status Date | 04/01/2004 |
Primary Code | 035 |
International Class - 041 - Education; providing of training; entertainment; sporting and cultural activities. | |
U.S. Class | 107 - Education and Entertainment |
Class Status | 6 - Active |
Status Date | 04/01/2004 |
Primary Code | 041 |
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
U.S. Class | 101 - Advertising and Business |
Class Status | 6 - Active |
Status Date | 04/01/2004 |
Primary Code | 042 |
Goods codes | |
D10000 | "CRO" |
GS0351 | Providing general business administration and management services on behalf of entities providing public or private clinical trials, medical studies or market research studies of pharmaceutical, pharmacogenomic, biotechnical, nutritional or medical products or devices in terms of evaluating third party clinical research sites for their ability to provide contractual research trade services; arranging of contractual trade services with selected third parties to perform such trials and studies; arranging of contractual trade services with third parties to collect and test laboratory specimens from clinical trial and study sites; and advertising and business management consultancy regarding clinical trials and studies and the recruitment of patients and consumers for such trials and studies |
GS0411 | Educational services in the nature of providing courses, training, testing and workshops in the field of clinical research, product lifecycle management, medical education, and distributing course materials in connection therewith; training clinical trial site and study site personnel in the use of tests and rating systems for protocol requirements; training clinical trial site personnel in the use of medical and research equipment required by trial and study protocols; and educational services in the nature of arranging for conference and seminar speakers through a speakers' bureau |
GS0421 | Product development and contract research services relating to public or private clinical trials or medical studies of pharmaceutical, pharmacies, nutritional, bio technical or medical products or devices; laboratory research testing in the fields of pharmacology, nutrition, biotechnology and medicine; conducting medical, scientific and data analysis research services for clinical trials or studies; development of clinical trial methodologies, protocol and project design, data retrieval methods, clinical data management and preparing statistical reports resulting from such clinical trials or studies; advisory services in the field of product development and research provided to physicians involved in the planning and preparation of lifecycle management activities for pharmaceutical, pharmacies, bio technical, nutritional, or medical products or devices; and technical consulting services in the nature of preparing and filing documents to comply with United States Food and Drug Administration requirements concerning clinical trials |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
09/28/2004 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
04/01/2004 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
02/03/2010 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
03/13/2007 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
03/13/2007 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
06/27/2006 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
06/27/2006 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
06/27/2006 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
12/27/2005 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
10/04/2005 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
09/14/2005 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
06/21/2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
06/15/2005 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
06/10/2005 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
06/03/2005 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
06/03/2005 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
06/01/2005 | EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEA - EXAMINERS AMENDMENT E-MAILED | |
06/01/2005 | EXAMINERS AMENDMENT -WRITTEN | R - Renewal | CNEA - EXAMINERS AMENDMENT -WRITTEN | |
05/06/2005 | AMENDMENT FROM APPLICANT ENTERED | I - Incoming Correspondence | ACEC - AMENDMENT FROM APPLICANT ENTERED | |
04/14/2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
04/14/2005 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
10/27/2004 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
10/12/2004 | EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION E-MAILED | F - First Action | GNPE - EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION E-MAILED | |
10/12/2004 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | R - Renewal | CPEA - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.